Moreover, the differences in SLC5A8 gene transcription and expression between FTA, FTC, and TT-UMP provide an important basis for further exploration of epigenetic changes in the occurrence, development, and prognosis of thyroid cancer, and provide possible potential molecular targets for the treatment of these tumors. Here, SLC5A8 is linked to thyroid cancer.